Joseph Thome

Stock Analyst at TD Cowen

(0)
# 5003
Out of 5,358 analysts
29
Total ratings
23.08%
Success rate
-28.37%
Average return
Main Sectors:
Top Industries:
22 Stocks
Name Action PT Current % Upside Ratings Updated
DRUG Bright Minds Bioscie...
Initiates Coverage On: Buy
n/a
n/a n/a 1 May 13, 2025
VRDN Viridian Therapeutic...
Initiates Coverage On: Buy
n/a
n/a n/a 1 Nov 25, 2024
MRNS Marinus Pharma
Downgrades: Hold
n/a
n/a n/a 2 Oct 25, 2024
UTHR United Therapeutics
Maintains: Strong Buy
350 400
325.81 22.77% 2 Oct 21, 2024
RAPP Rapport Therapeutics
Initiates Coverage On: Buy
n/a
n/a n/a 1 Jul 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
34
31.72 7.19% 1 Jun 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
80 90
n/a n/a 2 Apr 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
n/a
n/a n/a 1 Apr 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
32 30
52.11 -42.43% 2 Mar 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
45
n/a n/a 2 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Oct 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Dec 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Oct 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
120 130
111.92 16.15% 2 Jun 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
2
n/a n/a 1 Jun 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Nov 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 1 Jul 15, 2021